USA – Impiricus, an Atlanta, GA-based provider of tools which improve physician workflows with a focus on pharma services, raised $3M in Seed funding.
The round was led by FCA Venture Partners with participation from Surface Ventures.
The company intends to use the funds to further strengthen its team and scale provider acquisition to meet pharma demand for new go to market solutions.
Led by CEO Sandy Donaldson and Chief Product Officer Dr. Osama Hashmi, Impiricus uses artificial intelligence and a live team to help automate tasks and access resources and enable pharmaceutical companies and physicians to connect in order to serve their patients.
27/04/2022
